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Background: Creatinine clearance (CCr) and Hemoglobin (Hb) is readily-available laboratory test that can predict clinical outcomes in patients 
with acute MI. The aim of study was to evaluate impact of CCr and Hb composite index (CHI) on long-term clinical outcomes in patients with STEMI 
undergoing primary PCI with DES.
Methods: We analyzed consecutive 326 STEMI patients treated with primary PCI within 12 hours of onset of symptom. Cox regression analysis 
determined optimal combination of CCr and Hb into CHI. The discriminative ability of CHI, CCr and Hb in predicting 12-month MACE, composite of all 
cause of death, nonfatal MI and ischemic stroke were compared using area under receiving operating curve.
Results: The optimal weighting of CCR and Hb to form CHI to predict 12-month MACE was Hb + CCr/12. The area under the curve for CHI was 
significantly greater (0.857) than for Hb (0.777, p=0.003) and CCr (0.802, p=0.039). A positive trend between MACE and CHI quintiles was 
observed; 39.4%, 9.4%, 6.1%, 0.0%, 1.5% of MACE occurred from Q1 to Q5 (p <0.001). In a multivariable setting, patients with Q1 (vs. Q5) showed 
the highest 12-month MACE risk (HR: 26.77, 95% CI 2.86-250.66, p=0.004) after adjusting for standard risk factors. MACE-free survival rate was 
significantly lower in patients with Q1 compared to patients with other quintiles (p <0.001)
Conclusions: The CHI is a useful and powerful marker to predict 12-month MACE in patients with STEMI who underwent primary PCI, with a 
superior discriminative ability than CCr or Hb.
